Analystreport

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is now covered by analysts at Mizuho. They set a "buy" rating on the stock.

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report